Research Topics
Genomes and Genes
| Joan MassagueSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-? pathway and reveal microRNA regulation of TGFBR2Nikolaus Schultz
Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Silence 2:3. 2011..abstract:..
G1 cell-cycle control and cancerJoan Massague
Cancer Biology and Genetics Program, and Howard Hughes Medical Institute, Box 116, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10021, USA
Nature 432:298-306. 2004....
TGF-beta signal transductionJ Massague
Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Annu Rev Biochem 67:753-91. 1998..Mutations in these pathways are the cause of various forms of human cancer and developmental disorders...
The logic of TGFbeta signalingJoan Massague
Cancer Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, P O Box 116, 1275 York Avenue, New York, NY 10021, USA
FEBS Lett 580:2811-20. 2006..The deconstruction of one of these responses - the cell cycle arrest response - into its elemental molecular parts has shed light into the mechanisms used by tumors to evade surveillance and cause metastasis...
How cells read TGF-beta signalsJ Massague
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, Box 116, 1275 York Avenue, New York, New York 10021, USA
Nat Rev Mol Cell Biol 1:169-78. 2000..What are the networks of cell-specific molecules that mould the TGF-beta response to each cell's needs?..
Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional programQiaoran Xi
Cancer Biology and Genetics Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Biol Chem 283:1146-55. 2008..Our results provide a genome-wide scope of the participation of BRG1 in TGFbeta action and suggest a widespread yet differential involvement of BRG1 SWI/SNF remodeler in the transcriptional response of many genes to this cytokine...
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4David Padua
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cell 133:66-77. 2008....
Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signalingSheng Gao
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Mol Cell 36:457-68. 2009..Previously identified as a regulator of renal sodium channels, Nedd4L is shown here to play a broader role as a general modulator of Smad turnover during TGF-beta signal transduction...
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferationJoan Seoane
Cancer Biology and Genetics Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, 1300 York Avenue, New York, NY 1002, USA
Cell 117:211-23. 2004..We suggest that the activity of this network confers resistance to TGF-beta-mediated cytostasis during the development of the telencephalic neuroepithelium and in glioblastoma brain tumor cells...
Genes that mediate breast cancer metastasis to the brainPaula D Bos
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nature 459:1005-9. 2009..This co-option of a brain sialyltransferase highlights the role of cell-surface glycosylation in organ-specific metastatic interactions...
Balancing BMP signaling through integrated inputs into the Smad1 linkerGopal Sapkota
Cancer Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Mol Cell 25:441-54. 2007..The interplay between linker phosphorylation, Smurf-dependent ubiquitination, and nucleoporin exclusion enables regulation of BMP action by diverse signals and biological contexts...
Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear importLan Xu
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Biol Chem 278:42569-77. 2003....
WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasisDon X Nguyen
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cell 138:51-62. 2009..For a video summary of this article, see the PaperFlick file available with the online Supplemental Data...
Endogenous human microRNAs that suppress breast cancer metastasisSohail F Tavazoie
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nature 451:147-52. 2008..miR-335 and miR-126 are thus identified as metastasis suppressor microRNAs in human breast cancer...
Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damageJoan Seoane
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Nature 419:729-34. 2002..By inhibiting p21(Cip1) expression Myc favours the initiation of apoptosis, thereby influencing the outcome of a p53 response in favour of cell death...
A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cellsYibin Kang
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Mol Cell 11:915-26. 2003..As a common target of TGFbeta/Smad signals and stress signals via p38 kinase, ATF3 additionally serves to channel synergy between these pathways in the response of epithelial cells to stress and injury...
Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathwaysClaudio Alarcon
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell 139:757-69. 2009..Thus, nuclear CDK8/9 drive a cycle of Smad utilization and disposal that is an integral part of canonical BMP and TGF-beta pathways...
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathwayYibin Kang
Cancer Biology and Genetics Program and Howard Hughes Medical Institute, Molecular Cytology Laboratory, Memorial Sloan Kettering Cancer Center, NY 10021, USA
Proc Natl Acad Sci U S A 102:13909-14. 2005..Our findings provide functional evidence for a switch of the Smad pathway, from tumor-suppressor to prometastatic, in the development of breast cancer bone metastasis...
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathwayWei He
Cancer Biology and Genetics Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell 125:929-41. 2006..Thus, Smad2/3-TIF1gamma and Smad2/3-Smad4 function as complementary effector arms in the control of hematopoietic cell fate by the TGFbeta/Smad pathway...
Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathwaysGopal Sapkota
Cancer Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Biol Chem 281:40412-9. 2006....
C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cellsRoger R Gomis
Cancer Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Cell 10:203-14. 2006..We suggest that C/EBPbeta plays a key role in the coordination of TGFbeta cytostatic gene responses, and its malfunction may trigger evasion of these responses in breast cancer...
E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repressionChang Rung Chen
Cell Biology Program, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell 110:19-32. 2002..Smad proteins therefore mediate transcriptional activation or repression depending on their associated partners...
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungsThordur Oskarsson
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Nat Med 17:867-74. 2011..These findings link TNC to pathways that support the fitness of metastasis-initiating breast cancer cells and highlight the relevance of TNC as an extracellular matrix component of the metastatic niche...
Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-beta-mediated epithelial cell growth suppressionPeter M Siegel
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021
J Biol Chem 278:35444-50. 2003..These results argue that induction of Mad expression and Id2 down-regulation are important events during the TGF-beta cytostatic program in epithelial cells...
A multigenic program mediating breast cancer metastasis to boneYibin Kang
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer Cell 3:537-49. 2003....
Multimodality imaging of TGFbeta signaling in breast cancer metastasesInna Serganova
Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
FASEB J 23:2662-72. 2009....
Tumor self-seeding by circulating cancer cellsMi Young Kim
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cell 139:1315-26. 2009..Tumor self-seeding could explain the relationships between anaplasia, tumor size, vascularity and prognosis, and local recurrence seeded by disseminated cells following ostensibly complete tumor excision...
Genes that mediate breast cancer metastasis to lungAndy J Minn
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nature 436:518-24. 2005..Others contribute to aggressive growth selectively in the lung. Many encode extracellular proteins and are of previously unknown relevance to cancer metastasis...
Mediators of vascular remodelling co-opted for sequential steps in lung metastasisGaorav P Gupta
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nature 446:765-70. 2007..These findings reveal how aggressive primary tumorigenic functions can be mechanistically coupled to greater lung metastatic potential, and how such biological activities may be therapeutically targeted with specific drug combinations...
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H F Zhang
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Cancer Cell 16:67-78. 2009..Breast cancer cells that lodge in the bone marrow succumb in this environment when deprived of Src activity...
Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleusLan Xu
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Mol Cell 10:271-82. 2002..Thus, by directly contacting the nuclear pore complex, Smad2 undergoes constant shuttling, providing a dynamic pool that is competitively drawn by cytoplasmic and nuclear signal transduction partners...
Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analogThordur Oskarsson
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
J Am Chem Soc 132:3224-8. 2010..Both in vivo and in vitro studies indicate that ME exhibits a concentration-dependent inhibitory effect on migration of breast cancer cells...
A poised chromatin platform for TGF-? access to master regulatorsQiaoran Xi
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Cell 147:1511-24. 2011..In turn, Smad4 increases K18 acetylation to augment TRIM33-Smad2/3 binding. Thus, nodal effectors use the H3K9me3 mark as a platform to switch master regulators of stem cell differentiation from the poised to the active state...
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillanceDori A Thomas
Cancer Biology and Genetics Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer Cell 8:369-80. 2005..We suggest that TGF-beta suppresses CTL function in vivo through an anticytotoxic program of transcriptional repression...
Genetic determinants of cancer metastasisDon X Nguyen
Cancer Biology and Genetics Program, and Howard Hughes Medical Institute, Box 116, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10021, USA
Nat Rev Genet 8:341-52. 2007..With knowledge cemented in decades of research into tumour-initiating events, current experimental and conceptual models are beginning to address the genetic basis for cancer colonization of distant organs...
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancerKim J Png
Laboratory of Systems Cancer Biology, Rockefeller University, New York, NY 10065, USA
Genes Dev 25:226-31. 2011..We furthermore identify miR-335 as a robust inhibitor of tumor reinitiation. We thus implicate the miR-335 locus on 7q32.2 as the first selective metastasis suppressor and tumor initiation suppressor locus in human breast cancer...
ID genes mediate tumor reinitiation during breast cancer lung metastasisGaorav P Gupta
Cancer Biology and Genetics Program, Molecular Cytology Core Facility, Human Oncology and Pathogenesis Program, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Proc Natl Acad Sci U S A 104:19506-11. 2007..These results shed light on the proliferative mechanisms that initiate metastatic colonization, and they implicate Id1 and Id3 as mediators of this malignant function in the TN subgroup of breast cancers...
Roles of TGFbeta in metastasisDavid Padua
Cancer Biology and Genetics Program, and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 116, New York, NY 10065, USA
Cell Res 19:89-102. 2009..The development of TGFbeta inhibitors for clinical use will require a deeper understanding of TGFbeta signaling, its consequences, and the contexts in which it acts...
Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasisPeter M Siegel
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Proc Natl Acad Sci U S A 100:8430-5. 2003....
Smad transcription factorsJoan Massague
Cancer Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Genes Dev 19:2783-810. 2005..Our growing understanding of TGFbeta signaling through the Smad pathway provides general principles for how animal cells translate complex inputs into concrete behavior...
Breast cancer methylomes establish an epigenomic foundation for metastasisFang Fang
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Sci Transl Med 3:75ra25. 2011..These findings significantly enhance our understanding of breast cancer oncogenesis and aid the development of new prognostic biomarkers for this common malignancy...
Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungsQing Chen
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Cancer Cell 20:538-49. 2011..Thus, newly disseminated cancer cells expressing VCAM-1 can thrive in leukocyte-rich microenvironments through juxtacrine activation of a VCAM-1-Ezrin-PI3K/Akt survival pathway...
Clinical implications of cancer self-seedingElizabeth Comen
Department of Medicine, Memorial Sloan Kettering Cancer Center and the Weill College of Medicine of Cornell University, New York, NY 10021, USA
Nat Rev Clin Oncol 8:369-77. 2011..Indeed, reframing our understanding of metastasis within the self-seeding model offers new opportunities for prevention and cure of metastatic cancer...
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancerAnna Rodina
Program in Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Nat Chem Biol 3:498-507. 2007..These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells...
Modeling metastasis in the mousePaula D Bos
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Curr Opin Pharmacol 10:571-7. 2010..By integrating the information obtained with these complementary approaches the field is currently obtaining an unprecedented level of understanding of the biology, molecular basis, and therapeutic vulnerabilities of metastasis...
Metastasis: from dissemination to organ-specific colonizationDon X Nguyen
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Nat Rev Cancer 9:274-84. 2009....
A very private TGF-beta receptor embraceJoan Massague
Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Mol Cell 29:149-50. 2008..In this issue of Molecular Cell, Groppe et al. (2008) describe the crystal structure of a six-element TGF-beta:receptor complex, addressing long-standing questions about the restrictive nature of this vital receptor interaction...
TGFbeta in CancerJoan Massague
Cancer Biology and Genetics Program, and Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Cell 134:215-30. 2008..The mechanistic basis and clinical relevance of TGFbeta's role in cancer is becoming increasingly clear, paving the way for a better understanding of the complexity and therapeutic potential of this pathway...
HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoformsAnna Arnal-Estapé
Oncology Programme, Institute for Research in Biomedicine, Barcelona, Spain
Cancer Res 70:9927-36. 2010..Our findings reveal a novel mechanism through which HER2 silences tumor suppression in a concerted manner, contributing to the potency of this oncogene in breast cancer...
Integration of Smad and MAPK pathways: a link and a linker revisitedJoan Massague
Cancer Biology and Genetics Program, and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Genes Dev 17:2993-7. 2003
Research Grants
- Transforming Growth Factor-Beta Signal TransductionJoan Massague; Fiscal Year: 2007..Through this proposed work, we wish to furnish the field with a better understanding of the role of the TGFb/Smad pathway in physiology and a better ability to manage this pathway in tumor progression, metastasis and other disorders. ..
